{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,4]],"date-time":"2026-06-04T16:21:26Z","timestamp":1780590086579,"version":"3.54.1"},"reference-count":42,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2020,8,1]],"date-time":"2020-08-01T00:00:00Z","timestamp":1596240000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[2020,8,1]],"date-time":"2020-08-01T00:00:00Z","timestamp":1596240000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Endocrine"],"published-print":{"date-parts":[[2021,1]]},"DOI":"10.1007\/s12020-020-02435-w","type":"journal-article","created":{"date-parts":[[2020,8,1]],"date-time":"2020-08-01T18:02:46Z","timestamp":1596304966000},"page":"35-46","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":10,"title":["Meta-analysis of metabolic changes in children with idiopathic growth hormone deficiency after recombinant human growth hormone replacement therapy"],"prefix":"10.1007","volume":"71","author":[{"given":"Yuan","family":"Yuan","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bo","family":"Zhou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shufang","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yunfeng","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kundi","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-4914-1969","authenticated-orcid":false,"given":"Zhixin","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wenquan","family":"Niu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2020,8,1]]},"reference":[{"issue":"5","key":"2435_CR1","first-page":"401","volume":"105","author":"XL Bao","year":"1992","unstructured":"X.L. Bao, Y.F. Shi, Y.C. Du, R. Liu, J.Y. Deng, S.M. Gao, Prevalence of growth hormone deficiency of children in Beijing. Chin. Med. J. 105(5), 401\u2013405 (1992)","journal-title":"Chin. Med. J."},{"issue":"6","key":"2435_CR2","doi-asserted-by":"publisher","first-page":"737","DOI":"10.1016\/j.beem.2016.11.002","volume":"30","author":"A Chinoy","year":"2016","unstructured":"A. Chinoy, P.G. Murray, Diagnosis of growth hormone deficiency in the paediatric and transitional age. Best Pract. Res. Clin. Endocrinol. Metab. 30(6), 737\u2013747 (2016). https:\/\/doi.org\/10.1016\/j.beem.2016.11.002","journal-title":"Best Pract. Res. Clin. Endocrinol. Metab."},{"key":"2435_CR3","doi-asserted-by":"publisher","first-page":"44","DOI":"10.1016\/j.mce.2015.09.017","volume":"432","author":"RC Lindsey","year":"2016","unstructured":"R.C. Lindsey, S. Mohan, Skeletal effects of growth hormone and insulin-like growth factor-I therapy. Mol. Cell Endocrinol. 432, 44\u201355 (2016). https:\/\/doi.org\/10.1016\/j.mce.2015.09.017","journal-title":"Mol. Cell Endocrinol."},{"issue":"4","key":"2435_CR4","first-page":"379","volume":"37","author":"D Capalbo","year":"2012","unstructured":"D. Capalbo, A. Esposito, R. Di Mase, F. Barbieri, G. Parenti, P. Vajro, C. Pignata, M. Salerno, Update on early cardiovascular and metabolic risk factors in children and adolescents affected with growth hormone deficiency. Minerva Endocrinol. 37(4), 379\u2013389 (2012)","journal-title":"Minerva Endocrinol."},{"issue":"11","key":"2435_CR5","doi-asserted-by":"publisher","first-page":"4080","DOI":"10.1210\/jc.2017-00871","volume":"102","author":"D Capalbo","year":"2017","unstructured":"D. Capalbo, F. Barbieri, N. Improda, F. Giallauria, E. Di Pietro, A. Rapacciuolo, R. Di Mase, C. Vigorito, M. Salerno, Growth hormone improves cardiopulmonary capacity and body composition in children with growth hormone deficiency. J. Clin. Endocrinol. Metab. 102(11), 4080\u20134088 (2017). https:\/\/doi.org\/10.1210\/jc.2017-00871","journal-title":"J. Clin. Endocrinol. Metab."},{"issue":"46","key":"2435_CR6","doi-asserted-by":"publisher","first-page":"2335","DOI":"10.1055\/s-0034-1387314","volume":"139","author":"JH Quitmann","year":"2014","unstructured":"J.H. Quitmann, A.C. Rohenkohl, U. Kammerer, C. Schofl, M. Bullinger, H.G. Dorr, [Quality of life of young adults after a growth hormone therapy with childhood onset]. Dtsch. Med. Wochenschr. 139(46), 2335\u20132338 (2014). https:\/\/doi.org\/10.1055\/s-0034-1387314","journal-title":"Dtsch. Med. Wochenschr."},{"issue":"2","key":"2435_CR7","doi-asserted-by":"publisher","first-page":"405","DOI":"10.1016\/j.ecl.2016.01.005","volume":"45","author":"R Lanes","year":"2016","unstructured":"R. Lanes, Cardiovascular risk in growth hormone deficiency: beneficial effects of growth hormone replacement therapy. Endocrinol. Metab. Clin. North. Am. 45(2), 405\u2013418 (2016). https:\/\/doi.org\/10.1016\/j.ecl.2016.01.005","journal-title":"Endocrinol. Metab. Clin. North. Am."},{"issue":"6","key":"2435_CR8","doi-asserted-by":"publisher","first-page":"320","DOI":"10.1159\/000023298","volume":"50","author":"G Saggese","year":"1998","unstructured":"G. Saggese, M.B. Ranke, P. Saenger, R.G. Rosenfeld, T. Tanaka, J.L. Chaussain, M.O. Savage, Diagnosis and treatment of growth hormone deficiency in children and adolescents: towards a consensus. Ten years after the Availability of Recombinant Human Growth Hormone Workshop held in Pisa, Italy, 27-28 March 1998. Horm. Res. 50(6), 320\u2013340 (1998). https:\/\/doi.org\/10.1159\/000023298","journal-title":"Horm. Res."},{"issue":"6","key":"2435_CR9","doi-asserted-by":"publisher","first-page":"363","DOI":"10.1159\/000444143","volume":"85","author":"C De Leonibus","year":"2016","unstructured":"C. De Leonibus, S. De Marco, A. Stevens, P. Clayton, F. Chiarelli, A. Mohn, Growth hormone deficiency in prepubertal children: predictive markers of cardiovascular disease. Horm. Res. Paediatr. 85(6), 363\u2013371 (2016). https:\/\/doi.org\/10.1159\/000444143","journal-title":"Horm. Res. Paediatr."},{"issue":"6","key":"2435_CR10","doi-asserted-by":"publisher","first-page":"677","DOI":"10.1016\/j.beem.2016.12.001","volume":"30","author":"F Prodam","year":"2016","unstructured":"F. Prodam, P. Marzullo, G. Aimaretti, Growth hormone deficiency in children. Best Pract. Res. Clin. Endocrinol. Metab. 30(6), 677\u2013678 (2016). https:\/\/doi.org\/10.1016\/j.beem.2016.12.001","journal-title":"Best Pract. Res. Clin. Endocrinol. Metab."},{"issue":"1","key":"2435_CR11","doi-asserted-by":"publisher","first-page":"198","DOI":"10.1542\/peds.2008-1349","volume":"122","author":"SR Daniels","year":"2008","unstructured":"S.R. Daniels, F.R. Greer; Committee on Nutrition, Lipid screening and cardiovascular health in childhood. Pediatrics 122(1), 198\u2013208 (2008). https:\/\/doi.org\/10.1542\/peds.2008-1349","journal-title":"Pediatrics"},{"issue":"1","key":"2435_CR12","doi-asserted-by":"publisher","first-page":"95","DOI":"10.1097\/HCO.0000000000000249","volume":"31","author":"A Pires","year":"2016","unstructured":"A. Pires, C. Sena, R. Seica, Dyslipidemia and cardiovascular changes in children. Curr. Opin. Cardiol. 31(1), 95\u2013100 (2016). https:\/\/doi.org\/10.1097\/HCO.0000000000000249","journal-title":"Curr. Opin. Cardiol."},{"issue":"2","key":"2435_CR13","doi-asserted-by":"publisher","first-page":"73","DOI":"10.1159\/000450643","volume":"87","author":"J Rothermel","year":"2017","unstructured":"J. Rothermel, C. Knop, N. Lass, C. Toschke, R. Wunsch, T. Reinehr, Carotid intima-media thickness in children treated with growth hormone: a follow-up study over three years. Horm. Res. Paediatr. 87(2), 73\u201380 (2017). https:\/\/doi.org\/10.1159\/000450643","journal-title":"Horm. Res. Paediatr."},{"issue":"5","key":"2435_CR14","doi-asserted-by":"publisher","first-page":"954","DOI":"10.1038\/pr.2017.271","volume":"83","author":"M Chen","year":"2018","unstructured":"M. Chen, D. Gan, Y. Luo, S. Rampersad, L. Xu, S. Yang, N. Li, H. Li, Effect of recombinant human growth hormone therapy on blood lipid and carotid intima-media thickness in children with growth hormone deficiency. Pediatr. Res. 83(5), 954\u2013960 (2018). https:\/\/doi.org\/10.1038\/pr.2017.271","journal-title":"Pediatr. Res."},{"issue":"17","key":"2435_CR15","doi-asserted-by":"publisher","first-page":"3140","DOI":"10.1182\/blood-2010-05-280883","volume":"116","author":"M Crowther","year":"2010","unstructured":"M. Crowther, W. Lim, M.A. Crowther, Systematic review and meta-analysis methodology. Blood 116(17), 3140\u20133146 (2010). https:\/\/doi.org\/10.1182\/blood-2010-05-280883","journal-title":"Blood"},{"issue":"9","key":"2435_CR16","doi-asserted-by":"publisher","first-page":"712","DOI":"10.1046\/j.1445-2197.2003.02748.x","volume":"73","author":"K Slim","year":"2003","unstructured":"K. Slim, E. Nini, D. Forestier, F. Kwiatkowski, Y. Panis, J. Chipponi, Methodological index for non-randomized studies (minors): development and validation of a new instrument. ANZ J. Surg. 73(9), 712\u2013716 (2003)","journal-title":"ANZ J. Surg."},{"issue":"2","key":"2435_CR17","doi-asserted-by":"publisher","first-page":"455","DOI":"10.1111\/j.0006-341x.2000.00455.x","volume":"56","author":"S Duval","year":"2000","unstructured":"S. Duval, R. Tweedie, Trim and fill: a simple funnel-plot-based method of testing and adjusting for publication bias in meta-analysis. Biometrics 56(2), 455\u2013463 (2000). https:\/\/doi.org\/10.1111\/j.0006-341x.2000.00455.x","journal-title":"Biometrics"},{"issue":"2","key":"2435_CR18","doi-asserted-by":"publisher","first-page":"41","DOI":"10.1177\/2042018813484051","volume":"4","author":"W Lu","year":"2013","unstructured":"W. Lu, S. Shen, X. Luo, C. Gong, X. Gu, Y. Li, M. Du, R. Jin, Q. Zhou, W. Wang, Comparative evaluation of short-term biomarker response to treatment for growth hormone deficiency in Chinese children with growth hormone deficiency born small for or appropriate for gestational age: a randomized phase IV open-label study. Ther. Adv. Endocrinol. Metab. 4(2), 41\u201349 (2013). https:\/\/doi.org\/10.1177\/2042018813484051","journal-title":"Ther. Adv. Endocrinol. Metab."},{"key":"2435_CR19","doi-asserted-by":"publisher","first-page":"8469680","DOI":"10.1155\/2017\/8469680","volume":"2017","author":"A Ciresi","year":"2017","unstructured":"A. Ciresi, F. Ciccio, S. Radellini, V. Guarnotta, A.M. Calcaterra, C. Giordano, More favorable metabolic impact of three-times-weekly versus daily growth hormone treatment in naive GH-deficient children. Int. J. Endocrinol. 2017, 8469680 (2017). https:\/\/doi.org\/10.1155\/2017\/8469680","journal-title":"Int. J. Endocrinol."},{"issue":"2","key":"2435_CR20","doi-asserted-by":"publisher","first-page":"195","DOI":"10.1530\/EJE-16-0905","volume":"177","author":"X Luo","year":"2017","unstructured":"X. Luo, L. Hou, L. Liang, G. Dong, S. Shen, Z. Zhao, C.X. Gong, Y. Li, M.L. Du, Z. Su, H. Du, C. Yan, Long-acting PEGylated recombinant human growth hormone (Jintrolong) for children with growth hormone deficiency: phase II and phase III multicenter, randomized studies. Eur. J. Endocrinol. 177(2), 195\u2013205 (2017). https:\/\/doi.org\/10.1530\/EJE-16-0905","journal-title":"Eur. J. Endocrinol."},{"issue":"9\u201310","key":"2435_CR21","doi-asserted-by":"publisher","first-page":"909","DOI":"10.1515\/jpem-2013-0488","volume":"27","author":"C Foster","year":"2014","unstructured":"C. Foster, A. Burton, J. Scholl, M.L. Scott, V. Gunter, K. McCormick, Lipid patterns in treated growth hormone deficient children vs. short stature controls. J. Pediatr. Endocrinol. Metab. 27(9\u201310), 909\u2013914 (2014). https:\/\/doi.org\/10.1515\/jpem-2013-0488","journal-title":"J. Pediatr. Endocrinol. Metab."},{"issue":"10","key":"2435_CR22","doi-asserted-by":"publisher","first-page":"4700","DOI":"10.1210\/jcem.86.10.7932","volume":"86","author":"EO Reiter","year":"2001","unstructured":"E.O. Reiter, K.M. Attie, T. Moshang Jr., B.L. Silverman, S.F. Kemp, R.B. Neuwirth, K.M. Ford, P. Saenger, Genentech IAICSG, A multicenter study of the efficacy and safety of sustained release GH in the treatment of naive pediatric patients with GH deficiency. J. Clin. Endocrinol. Metab. 86(10), 4700\u20134706 (2001). https:\/\/doi.org\/10.1210\/jcem.86.10.7932","journal-title":"J. Clin. Endocrinol. Metab."},{"issue":"10","key":"2435_CR23","doi-asserted-by":"publisher","first-page":"3653","DOI":"10.1210\/jcem.85.10.6906","volume":"85","author":"N Mauras","year":"2000","unstructured":"N. Mauras, K.M. Attie, E.O. Reiter, P. Saenger, J. Baptista, High dose recombinant human growth hormone (GH) treatment of GH-deficient patients in puberty increases near-final height: a randomized, multicenter trial. Genentech, Inc., Cooperative Study Group. J. Clin. Endocrinol. Metab. 85(10), 3653\u20133660 (2000). https:\/\/doi.org\/10.1210\/jcem.85.10.6906","journal-title":"J. Clin. Endocrinol. Metab."},{"issue":"5","key":"2435_CR24","doi-asserted-by":"publisher","first-page":"2089","DOI":"10.1210\/jc.2009-2139","volume":"95","author":"P Cohen","year":"2010","unstructured":"P. Cohen, J. Germak, A.D. Rogol, W. Weng, A.M. Kappelgaard, R.G. Rosenfeld; American Norditropin Study Group, Variable degree of growth hormone (GH) and insulin-like growth factor (IGF) sensitivity in children with idiopathic short stature compared with GH-deficient patients: evidence from an IGF-based dosing study of short children. J. Clin. Endocrinol. Metab. 95(5), 2089\u20132098 (2010). https:\/\/doi.org\/10.1210\/jc.2009-2139","journal-title":"J. Clin. Endocrinol. Metab."},{"issue":"5","key":"2435_CR25","doi-asserted-by":"publisher","first-page":"1647","DOI":"10.3892\/etm.2016.3091","volume":"11","author":"Y Xue","year":"2016","unstructured":"Y. Xue, Y. Gao, S. Wang, P. Wang, An examination of the effects of different doses of recombinant human growth hormone on children with growth hormone deficiency. Exp. Ther. Med. 11(5), 1647\u20131652 (2016). https:\/\/doi.org\/10.3892\/etm.2016.3091","journal-title":"Exp. Ther. Med."},{"issue":"7","key":"2435_CR26","doi-asserted-by":"publisher","first-page":"879","DOI":"10.1530\/EC-18-0135","volume":"7","author":"A Ciresi","year":"2018","unstructured":"A. Ciresi, S. Radellini, V. Guarnotta, M.G. Mineo, C. Giordano, The metabolic outcomes of growth hormone treatment in children are gender specific. Endocr. Connect. 7(7), 879\u2013887 (2018). https:\/\/doi.org\/10.1530\/EC-18-0135","journal-title":"Endocr. Connect."},{"issue":"2","key":"2435_CR27","doi-asserted-by":"publisher","first-page":"400","DOI":"10.1210\/jc.2011-2234","volume":"97","author":"F Peter","year":"2012","unstructured":"F. Peter, M. Bidlingmaier, C. Savoy, H.J. Ji, P.H. Saenger, Three-year efficacy and safety of LB03002, a once-weekly sustained-release growth hormone (GH) preparation, in prepubertal children with GH deficiency (GHD). J. Clin. Endocrinol. Metab. 97(2), 400\u2013407 (2012). https:\/\/doi.org\/10.1210\/jc.2011-2234","journal-title":"J. Clin. Endocrinol. Metab"},{"issue":"1","key":"2435_CR28","doi-asserted-by":"publisher","first-page":"42","DOI":"10.1530\/eje.0.1420042","volume":"142","author":"G Radetti","year":"2000","unstructured":"G. Radetti, F. Buzi, C. Paganini, C. Martelli, S. Adami, A four year dose-response study of recombinant human growth hormone treatment of growth hormone deficient children: effects on growth, bone growth and bone mineralization. Eur. J. Endocrinol. 142(1), 42\u201346 (2000). https:\/\/doi.org\/10.1530\/eje.0.1420042","journal-title":"Eur. J. Endocrinol."},{"issue":"3","key":"2435_CR29","doi-asserted-by":"publisher","first-page":"1091","DOI":"10.1210\/jc.2015-3279","volume":"101","author":"WV Moore","year":"2016","unstructured":"W.V. Moore, H.J. Nguyen, G.B. Kletter, B.S. Miller, D. Rogers, D. Ng, J.A. Moore, E. Humphriss, J.L. Cleland, G.M. Bright, A. Randomized Safety and Efficacy Study of Somavaratan (VRS-317), a long-acting rhGH, in pediatric growth hormone deficiency. J. Clin. Endocrinol. Metab. 101(3), 1091\u20131097 (2016). https:\/\/doi.org\/10.1210\/jc.2015-3279","journal-title":"J. Clin. Endocrinol. Metab."},{"issue":"15","key":"2435_CR30","doi-asserted-by":"publisher","first-page":"6983","DOI":"10.1073\/pnas.89.15.6983","volume":"89","author":"M Rudling","year":"1992","unstructured":"M. Rudling, G. Norstedt, H. Olivecrona, E. Reihner, J.A. Gustafsson, B. Angelin, Importance of growth hormone for the induction of hepatic low density lipoprotein receptors. Proc. Natl Acad. Sci. USA 89(15), 6983\u20136987 (1992). https:\/\/doi.org\/10.1073\/pnas.89.15.6983","journal-title":"Proc. Natl Acad. Sci. USA"},{"issue":"4","key":"2435_CR31","doi-asserted-by":"publisher","first-page":"1113","DOI":"10.1210\/jcem.80.4.7714078","volume":"80","author":"H Olivecrona","year":"1995","unstructured":"H. Olivecrona, S. Ericsson, B. Angelin, Growth hormone treatment does not alter biliary lipid metabolism in healthy adult men. J. Clin. Endocrinol. Metab. 80(4), 1113\u20131117 (1995). https:\/\/doi.org\/10.1210\/jcem.80.4.7714078","journal-title":"J. Clin. Endocrinol. Metab."},{"issue":"2","key":"2435_CR32","doi-asserted-by":"publisher","first-page":"296","DOI":"10.1161\/01.atv.13.2.296","volume":"13","author":"S Eden","year":"1993","unstructured":"S. Eden, O. Wiklund, J. Oscarsson, T. Rosen, B.A. Bengtsson, Growth hormone treatment of growth hormone-deficient adults results in a marked increase in Lp(a) and HDL cholesterol concentrations. Arterioscler. Thromb. 13(2), 296\u2013301 (1993). https:\/\/doi.org\/10.1161\/01.atv.13.2.296","journal-title":"Arterioscler. Thromb."},{"issue":"2","key":"2435_CR33","doi-asserted-by":"publisher","first-page":"349","DOI":"10.1161\/01.ATV.0000110657.67317.90","volume":"24","author":"S Lind","year":"2004","unstructured":"S. Lind, M. Rudling, S. Ericsson, H. Olivecrona, M. Eriksson, B. Borgstrom, G. Eggertsen, L. Berglund, B. Angelin, Growth hormone induces low-density lipoprotein clearance but not bile acid synthesis in humans. Arterioscler. Thromb. Vasc. Biol. 24(2), 349\u2013356 (2004). https:\/\/doi.org\/10.1161\/01.ATV.0000110657.67317.90","journal-title":"Arterioscler. Thromb. Vasc. Biol."},{"key":"2435_CR34","doi-asserted-by":"publisher","first-page":"5484138","DOI":"10.1155\/2019\/5484138","volume":"2019","author":"AM Mahmoud","year":"2019","unstructured":"A.M. Mahmoud, R.J. Hernandez Bautista, M.A. Sandhu, O.E. Hussein, Beneficial effects of citrus flavonoids on cardiovascular and metabolic health. Oxid. Med. Cell. Longev. 2019, 5484138 (2019). https:\/\/doi.org\/10.1155\/2019\/5484138","journal-title":"Oxid. Med. Cell. Longev"},{"issue":"2","key":"2435_CR35","doi-asserted-by":"publisher","first-page":"314","DOI":"10.1016\/j.jpeds.2011.01.038","volume":"159","author":"O Guardamagna","year":"2011","unstructured":"O. Guardamagna, F. Abello, G. Anfossi, M. Pirro, Lipoprotein(a) and family history of cardiovascular disease in children with familial dyslipidemias. J. Pediatr. 159(2), 314\u2013319 (2011). https:\/\/doi.org\/10.1016\/j.jpeds.2011.01.038","journal-title":"J. Pediatr."},{"issue":"5","key":"2435_CR36","doi-asserted-by":"publisher","first-page":"464","DOI":"10.1111\/j.1399-5448.2008.00406.x","volume":"9","author":"Z Quijada","year":"2008","unstructured":"Z. Quijada, M. Paoli, Y. Zerpa, N. Camacho, R. Cichetti, V. Villarroel, G. Arata-Bellabarba, R. Lanes, The triglyceride\/HDL-cholesterol ratio as a marker of cardiovascular risk in obese children; association with traditional and emergent risk factors. Pediatr. Diabetes 9(5), 464\u2013471 (2008). https:\/\/doi.org\/10.1111\/j.1399-5448.2008.00406.x","journal-title":"Pediatr. Diabetes"},{"issue":"9","key":"2435_CR37","doi-asserted-by":"publisher","first-page":"3347","DOI":"10.1210\/jc.2008-2639","volume":"94","author":"D Capalbo","year":"2009","unstructured":"D. Capalbo, A. Lo Vecchio, V. Farina, L. Spinelli, A. Palladino, C. Tiano, T. Lettiero, G. Lombardi, A. Colao, M. Salerno, Subtle alterations of cardiac performance in children with growth hormone deficiency: results of a two-year prospective, case-control study. J. Clin. Endocrinol. Metab. 94(9), 3347\u20133355 (2009). https:\/\/doi.org\/10.1210\/jc.2008-2639","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"2435_CR38","doi-asserted-by":"publisher","first-page":"174","DOI":"10.3389\/fped.2018.00174","volume":"6","author":"E Gomez-Guzman","year":"2018","unstructured":"E. Gomez-Guzman, M.D. Canete, R. Valle-Martos, R. Canete, M. Valle, L. Jimenez-Reina, J. Caballero-Villarraso, Short-term evaluation of left ventricular mass and function in children with growth hormone deficiency after replacement treatment. Front. Pediatr. 6, 174 (2018). https:\/\/doi.org\/10.3389\/fped.2018.00174","journal-title":"Front. Pediatr."},{"issue":"9","key":"2435_CR39","doi-asserted-by":"publisher","first-page":"432","DOI":"10.1055\/s-2007-1001724","volume":"26","author":"C Azzarito","year":"1994","unstructured":"C. Azzarito, L. Boiardi, M. Zini, A. Agosti, M. Biacchessi, R. Biagi, I. Portioli, Short and long-term effects of growth hormone treatment on lipid, lipoprotein, and apolipoprotein levels in short normal children. Horm. Metab. Res. 26(9), 432\u2013435 (1994). https:\/\/doi.org\/10.1055\/s-2007-1001724","journal-title":"Horm. Metab. Res."},{"issue":"5","key":"2435_CR40","doi-asserted-by":"publisher","first-page":"876","DOI":"10.4103\/2230-8210.117234","volume":"17","author":"KA Metwalley","year":"2013","unstructured":"K.A. Metwalley, H.S. Farghaly, H.A. Abd El-Hafeez, Evaluation of left ventricular mass and function, lipid profile, and insulin resistance in Egyptian children with growth hormone deficiency: a single-center prospective case-control study. Indian J. Endocrinol. Metab. 17(5), 876\u2013882 (2013). https:\/\/doi.org\/10.4103\/2230-8210.117234","journal-title":"Indian J. Endocrinol. Metab."},{"issue":"6","key":"2435_CR41","doi-asserted-by":"publisher","first-page":"E1025","DOI":"10.1210\/jc.2010-3023","volume":"96","author":"CJ Child","year":"2011","unstructured":"C.J. Child, A.G. Zimmermann, R.S. Scott, G.B. Cutler Jr., T. Battelino, W.F. Blum; GeNe SISIAB, Prevalence and incidence of diabetes mellitus in GH-treated children and adolescents: analysis from the GeNeSIS observational research program. J. Clin. Endocrinol. Metab. 96(6), E1025\u2013E1034 (2011). https:\/\/doi.org\/10.1210\/jc.2010-3023","journal-title":"J. Clin. Endocrinol. Metab."},{"issue":"3","key":"2435_CR42","doi-asserted-by":"publisher","first-page":"196","DOI":"10.1159\/000448841","volume":"86","author":"F Baronio","year":"2016","unstructured":"F. Baronio, L. Mazzanti, Y. Girtler, F. Tamburrino, A. Fazzi, F. Lupi, S. Longhi, G. Radetti, The influence of growth hormone treatment on glucose homeostasis in growthhormone-deficient children: a six-year follow-up study. Horm. Res. Paediatr. 86(3), 196\u2013200 (2016). https:\/\/doi.org\/10.1159\/000448841","journal-title":"Horm. Res. Paediatr"}],"container-title":["Endocrine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s12020-020-02435-w.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s12020-020-02435-w\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s12020-020-02435-w.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,7,31]],"date-time":"2021-07-31T23:34:16Z","timestamp":1627774456000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s12020-020-02435-w"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,8,1]]},"references-count":42,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2021,1]]}},"alternative-id":["2435"],"URL":"https:\/\/doi.org\/10.1007\/s12020-020-02435-w","relation":{},"ISSN":["1355-008X","1559-0100"],"issn-type":[{"value":"1355-008X","type":"print"},{"value":"1559-0100","type":"electronic"}],"subject":[],"published":{"date-parts":[[2020,8,1]]},"assertion":[{"value":"19 May 2020","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"23 July 2020","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"1 August 2020","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Compliance with ethical standards"}},{"value":"The authors declare that they have no conflict of interest.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}},{"value":"Ethical approval is waived for the present study because this is a meta-analysis based on the results of individual studies that had been reviewed and approved by localized ethics committees.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethical approval"}}]}}